| The 2019 Genitourinary Pathology Society (GUPS) white paper on contemporary grading of prostate cancer JI Epstein, MB Amin, SW Fine, F Algaba, M Aron, DE Baydar, AL Beltran, ... Archives of pathology & laboratory medicine 145 (4), 461-493, 2021 | 197 | 2021 |
| Evidence for molecular differences in prostate cancer between African American and Caucasian men F Khani, JM Mosquera, K Park, M Blattner, C O'Reilly, TY MacDonald, ... Clinical Cancer Research 20 (18), 4925-4934, 2014 | 174 | 2014 |
| SPOP mutations in prostate cancer across demographically diverse patient cohorts M Blattner, DJ Lee, C O'Reilly, K Park, TY MacDonald, F Khani, KR Turner, ... Neoplasia 16 (1), 14-W10, 2014 | 174 | 2014 |
| Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling BD Robinson, PJ Vlachostergios, B Bhinder, W Liu, K Li, TJ Moss, ... Nature communications 10 (1), 2977, 2019 | 171 | 2019 |
| Exome Sequencing of African-American Prostate Cancer Reveals Loss-of-Function ERF Mutations FW Huang, JM Mosquera, A Garofalo, C Oh, M Baco, A Amin-Mansour, ... Cancer discovery 7 (9), 973-983, 2017 | 122 | 2017 |
| Concordance between biopsy and radical prostatectomy pathology in the era of targeted biopsy: a systematic review and meta-analysis S Goel, JE Shoag, MD Gross, BAH Al Awamlh, B Robinson, F Khani, ... European urology oncology 3 (1), 10-20, 2020 | 84 | 2020 |
| Prostate biopsy specimens with Gleason 3+ 3= 6 and intraductal carcinoma: radical prostatectomy findings and clinical outcomes F Khani, JI Epstein The American Journal of Surgical Pathology 39 (10), 1383-1389, 2015 | 83 | 2015 |
| Subtype heterogeneity and epigenetic convergence in neuroendocrine prostate cancer P Cejas, Y Xie, A Font-Tello, K Lim, S Syamala, X Qiu, AK Tewari, N Shah, ... Nature communications 12 (1), 5775, 2021 | 80 | 2021 |
| Variant PNLDC1, Defective piRNA Processing, and Azoospermia L Nagirnaja, N Mørup, JE Nielsen, R Stakaitis, I Golubickaite, MS Oud, ... New England Journal of Medicine 385 (8), 707-719, 2021 | 67 | 2021 |
| Androgen deprivation upregulates SPINK1 expression and potentiates cellular plasticity in prostate cancer R Tiwari, N Manzar, V Bhatia, A Yadav, MA Nengroo, D Datta, ... Nature Communications 11 (1), 384, 2020 | 67 | 2020 |
| The learning curve for magnetic resonance imaging/ultrasound fusion-guided prostate biopsy K Kasabwala, N Patel, E Cricco-Lizza, AA Shimpi, S Weng, ... European Urology Oncology 2 (2), 135-140, 2019 | 64 | 2019 |
| Functional outcomes following robotic prostatectomy using athermal, traction free risk-stratified grades of nerve sparing AK Tewari, A Ali, S Metgud, N Theckumparampil, A Srivastava, F Khani, ... World journal of urology 31, 471-480, 2013 | 58 | 2013 |
| Temporal evolution of cellular heterogeneity during the progression to advanced AR-negative prostate cancer NJ Brady, AM Bagadion, R Singh, V Conteduca, L Van Emmenis, E Arceci, ... Nature communications 12 (1), 3372, 2021 | 56 | 2021 |
| Computationally derived image signature of stromal morphology is prognostic of prostate cancer recurrence following prostatectomy in African American patients HK Bhargava, P Leo, R Elliott, A Janowczyk, J Whitney, S Gupta, P Fu, ... Clinical Cancer Research 26 (8), 1915-1923, 2020 | 55 | 2020 |
| Intraductal carcinoma of the prostate in the absence of high‐grade invasive carcinoma represents a molecularly distinct type of in situ carcinoma enriched with … F Khani, SE Wobker, JL Hicks, BD Robinson, CE Barbieri, AM De Marzo, ... The Journal of Pathology 249 (1), 79-89, 2019 | 51 | 2019 |
| Association of oncofetal protein expression with clinical outcomes in patients with urothelial carcinoma of the bladder E Xylinas, EK Cha, F Khani, LA Kluth, M Rieken, BG Volkmer, ... The Journal of urology 191 (3), 830-841, 2014 | 42 | 2014 |
| Immune activation induces immortalization of HTLV-1 LTR-Tax transgenic CD4+ T cells AY Swaims, F Khani, Y Zhang, AI Roberts, S Devadas, Y Shi, AB Rabson Blood, The Journal of the American Society of Hematology 116 (16), 2994-3003, 2010 | 42 | 2010 |
| Landscape of prostate-specific membrane antigen heterogeneity and regulation in AR-positive and AR-negative metastatic prostate cancer MK Bakht, Y Yamada, SY Ku, VB Venkadakrishnan, JA Korsen, ... Nature cancer 4 (5), 699-715, 2023 | 40 | 2023 |
| Interobserver reproducibility of percent Gleason pattern 4 in prostatic adenocarcinoma on prostate biopsies ET Sadimin, F Khani, M Diolombi, A Meliti, JI Epstein The American journal of surgical pathology 40 (12), 1686-1692, 2016 | 39 | 2016 |
| Population-based study of the incidence and survival for intraductal carcinoma of the prostate BF Dinerman, F Khani, R Golan, AN Bernstein, MF Cosiano, DJ Margolis, ... Urologic Oncology: Seminars and Original Investigations 35 (12), 673. e9-673 …, 2017 | 38 | 2017 |
Christopher BarbieriAssociate Professor of Urology, Weill Cornell Medicine在 med.cornell.edu 的电子邮件经过验证
